Nontricyclic antidepressant agents derived from cis- and trans-1-amino-4-aryltetralins
- 1 November 1984
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 27 (11), 1508-1515
- https://doi.org/10.1021/jm00377a021
Abstract
The need for drugs that lack the obtrusive and limiting side effects of the tricyclic antidepressants prompted the search for agents with greatly enhanced selectivity for specific mechanisms believed to be essential for antidepressant efficacy. The potential role of derangements of 5-HT [5-hydroxytryptamine] pathways in the etiology of depression was long suspected and gave impetus to the development of newer compounds that accentuate inhibition of serotonin reuptake. This paper presents structure-activity relationships for a series of cis-1-amino-4-(substituted-aryl)tetralins, which are surprisingly potent and selective inhibitors of serotonin uptake in in vitro models. These compounds are pharmacologically distinct from corresponding members of the trans series, which also potently block uptake of dopamine and norepinephrine in rats. The activity in both cis and trans series is stereospecific, being restricted to the cis-(1S,4S) and the trans-(1R,4S) enantiomers.This publication has 5 references indexed in Scilit:
- SERTRALINE, 1S,4S-N-METHYL-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHYLAMINE, A NEW UPTAKE INHIBITOR WITH SELECTIVITY FOR SEROTONIN1983
- Intravenous Self-Administration of Nomifensine in Rats: Implications for Abuse Potential in HumansScience, 1981
- Biogenic amine hypothesis of affective disordersLife Sciences, 1979
- MOLECULAR-GEOMETRY OF INHIBITORS OF UPTAKE OF CATECHOLAMINES AND SEROTONIN IN SYNAPTOSOMAL PREPARATIONS OF RAT-BRAIN1976
- USE OF SYNTHESIS INHIBITORS IN DEFINING A ROLE FOR BIOGENIC-AMINES DURING IMIPRAMINE TREATMENT IN DEPRESSED-PATIENTS1975